Marc Y. Fink

United States Food and Drug Administration

Also affiliated with Center for Drug Evaluation and Research, Georgetown University

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Impact of body mass index on the efficacy of aromatase inhibitors in patients with metastatic breast cancer”.

Impact of body mass index on the efficacy of aromatase inhibitors in patients with metastatic breast cancer

Breast Cancer Research and Treatment(2022)10.1007/s10549-021-06504-0

N/A

0.345DataRank · unranked

9 citations

Zhiqiang Li, Brittney S. Zimmerman, Marc Y. Fink, Jason D. Wells, Xiang Zhou +8 more

Giardia intestinalis reshapes mucosal immunity toward a Type 2 response that attenuates inflammatory bowel-like diseases

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.02.583119

N/A

0DataRank · unranked

3 citations

Pedro Henrique Gazzinelli-Guimarães, Oluwaremilekun G. Ajakaye, Tiago Rodrigues Ferreira, Eliza V.C. Alves‐Ferreira, Erick T. Tjhin +6 more

Giardia increases macrophage production of the anti-inflammatory cytokine interleukin-10 in response to lipopolysaccharide via macrophage galactose binding lectin

ImmunoHorizons(2025)10.1093/immhor/vlaf019

N/A

0DataRank · unranked

0 citations

Rita Taye Kosile, Matthew Darmadi, Eleanor G Miskovsky, Marc Y. Fink, Samantha Menegas +3 more